Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DYDROGESTERONE vs EFALIZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DYDROGESTERONE vs EFALIZUMAB: Safety Overview

Metric DYDROGESTERONE EFALIZUMAB
Total FAERS Reports 340 230
Deaths Reported 13 73
Death Rate 3.8% 31.7%
Hospitalizations 112 44
Average Patient Age 33.8 yrs 52.3 yrs
% Female Patients 94.4% 46.2%
FDA Approval Date Approved Prior to Jan 1, 1982 N/A
Marketing Status Discontinued N/A